Stockscreener 앱 받기
17.28
1.20%
-0.21
시간 외 거래:
17.28
전일 마감가:
$17.49
열려 있는:
$17.47
하루 거래량:
608.24K
Relative Volume:
0.83
시가총액:
$1.41B
수익:
$288.00K
순이익/손실:
$-228.06M
주가수익비율:
-4.0659
EPS:
-4.25
순현금흐름:
$-168.82M
1주 성능:
+4.60%
1개월 성능:
+17.55%
6개월 성능:
-6.34%
1년 성능:
+5.75%
1일 변동 폭
$16.80
$17.62
1주일 범위
$16.57
$18.44
52주 변동 폭
$9.90
$27.20
Viridian Therapeutics Inc Stock (VRDN) Company Profile
명칭
Viridian Therapeutics Inc
전화
617.272.4600
주소
221 CRESCENT STREET, WALTHAM
VRDN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRDN
Viridian Therapeutics Inc
|
17.28 | 1.43B | 288.00K | -228.06M | -168.82M | -4.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-25 | 개시 | TD Cowen | Buy |
| 2024-09-11 | 재확인 | Needham | Buy |
| 2024-06-11 | 개시 | Wolfe Research | Outperform |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-05-09 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2023-06-14 | 개시 | BTIG Research | Buy |
| 2023-06-14 | 재개 | Credit Suisse | Outperform |
| 2023-05-30 | 개시 | RBC Capital Mkts | Outperform |
| 2023-04-17 | 개시 | Wells Fargo | Overweight |
| 2023-03-30 | 개시 | Stifel | Buy |
| 2022-12-19 | 개시 | Cowen | Outperform |
| 2022-12-19 | 개시 | Needham | Buy |
| 2022-12-16 | 개시 | Credit Suisse | Outperform |
| 2022-12-01 | 개시 | H.C. Wainwright | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-11-18 | 개시 | SVB Leerink | Outperform |
| 2021-10-12 | 개시 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스
What is the dividend policy of Viridian Therapeutics Inc. stockInvest confidently with market-leading analysis - jammulinksnews.com
What institutional investors are buying Viridian Therapeutics Inc. stockSuperior returns - jammulinksnews.com
How does Viridian Therapeutics Inc. compare to its industry peersGet real-time alerts on high-potential stocks - jammulinksnews.com
What makes Viridian Therapeutics Inc. stock price move sharplyOutstanding risk-reward balance - jammulinksnews.com
Intrinsic Value of Viridian Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Stock Selection with 300% Return - Newser
Insider Buying and Strategic Alignment at Viridian Therapeutics: A Signal for Biotech Investors - AInvest
Viridian Therapeutics Inc. Stock Support and Resistance Levels You Should Know - Newser
Key External Factors That Drive Viridian Therapeutics Inc. Stock Price MovementsDaily Gain Forecast - Newser
Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings - Yahoo.co
Competitive Positioning of Viridian Therapeutics Inc.: Is It Leading or LaggingReal Time Alert Service - Newser
What drives Viridian Therapeutics Inc. stock priceFree Stock Movement Tracking - PrintWeekIndia
Viridian Therapeutics Inc. Stock Analysis and ForecastTremendous return rates - Autocar Professional
What analysts say about Viridian Therapeutics Inc. stockLightning-fast growth - PrintWeekIndia
How Viridian Therapeutics Inc. stock performs during market volatilityMarket Ready Callouts - Newser
Is Viridian Therapeutics Inc. a good long term investmentExplosive trading opportunities - Autocar Professional
Viridian Therapeutics’ Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial - MSN
Why Viridian Therapeutics Inc. stock attracts strong analyst attentionBreakout Level Watch - Newser
Teacher Retirement System of Texas Decreases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
(VRDN) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Principal Financial Group Inc. Acquires 30,392 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
Viridian Therapeutics Inc (VRDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
0.22%
자본화:
|
볼륨(24시간):